Results 181 to 190 of about 3,675 (259)
A Self‐Driving Lab for Solution‐Processed Electrochromic Thin Films
A self‐driving laboratory accelerates the development of solution‐processed electrochromic thin films. By coupling machine learning with robotic fabrication and characterization, this closed‐loop platform systematically navigates complex processing parameters.
Selma Dahms +7 more
wiley +1 more source
Inflammatory disease progression shapes nanoparticle biomolecular corona-mediated immune activation profiles. [PDF]
Shaw JR +9 more
europepmc +1 more source
ABSTRACT The rapid evolution of the Internet of Things (IoT) has significantly advanced the field of electrocardiogram (ECG) monitoring, enabling real‐time, remote, and patient‐centric cardiac care. This paper presents a comprehensive survey of AI assisted IoT‐based ECG monitoring systems, focusing on the integration of emerging technologies such as ...
Amrita Choudhury +2 more
wiley +1 more source
Profiling Glycoproteins Enriched by Multinanoparticle Protein Corona. [PDF]
Sutherland E +4 more
europepmc +1 more source
Pathogenic PF4/Polyanion ELISA‐Negative Antibodies in HIT
ABSTRACT Background Platelet factor 4‐polyanion enzyme‐linked immunosorbent assays (ELISAs) are considered highly sensitive for diagnosing heparin‐induced thrombocytopenia (HIT), such that current practice guidelines recommend use of ELISA‐negative results to exclude HIT.
Adam J. Kanack +25 more
wiley +1 more source
PAK-family kinases promote cell fusion irreversibility by preventing cell wall repair
Coronas-Serna JM +2 more
europepmc +1 more source
Polymeric Nanogels for Skin Applications. [PDF]
Silva S, Machado M, Costa EM.
europepmc +1 more source
ABSTRACT Talquetamab is a GPRC5D × CD3 bispecific antibody approved for relapsed/refractory multiple myeloma (RRMM). This is the first real‐world study to comprehensively report muco‐cutaneous toxicities, infections, and efficacy of talquetamab in 151 patients across five countries with the longest follow‐up reported enabling better efficacy and ...
Murali Janakiram +94 more
wiley +1 more source

